Everand Logo

Welcome to Everand!

  • STAT

    MIT’s Koch Institute wins STAT Madness with technology to see tiny ovarian tumors

    Carbon nanotubes rule: Each STAT Madness finalist exploited carbon nanotubes to tackle one of the two leading causes of death in the U.S. — heart disease and cancer.
    by Elizabeth Cooney Apr 06, 2020 5 minutes

    Carbon nanotubes rule.

    In this year’s STAT Madness, a bracket-style competition to honor the best in recent biomedical research, each finalist exploited carbon nanotubes to tackle one of the two leading causes of death in the U.S.: heart disease and cancer. 

    One finalist, a team from MIT’s Koch Institute for Integrative Cancer Research, engineered a fluorescing carbon nanotubule — an “amazing” material — to better see the multitude of tiny ovarian cancer tumors deep in the body and unseen by a surgeon’s eyes. The other finalist, from the Texas Heart Institute and Rice University, created fibers from “magical” carbon nanotubes to bridge over scarred heart tissue following a heart attack to prevent deadly rhythm disturbances. 

    After five weeks and a record-setting 699,315 votes, we have a champion: the Koch

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related